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ABSTRACT 
Objectives: A survey was conducted in Dakar, Senegal, to iden- 
tify major types and prevalences of bacteria, parasites, fungi, 
and Rotaviruses associated with diarrhea in relation to human 
immunodeficieny virus (HIV) serostatus with the goal to pro- 
vide guidance to physicians for case management. 
Methods: Etiologic agents were identified in a case-control 
study: cases were HIV-infected patients with diarrhea (HIV+ D+) 
and HIV seronegative patients with diarrhea (HIV- D+); con- 
trols were HIV-infected patients without diarrhea (HIV+ D-) and 
seronegative controls without diarrhea (HID- D-). Ordinary 
enteric pathogens were identified by conventional methods. 
Different Escherichia co/i pathotypes were characterized by 
polymerase chain reaction (PCR), identification of HEp-2 cell 
adherence pattern, Sereny test, GM1 -ELISA, and the suckling 
mouse assay. Opportunistic parasites, such as Cryptosporid- 
ium and Microsporidium, were identified by the Kinyoun method 
and trichromic stain of Weber, respectively. Rotaviruses were 
identified with a commercial latex agglutination kit. Antimicro- 
bial susceptibility testing was carried out by the disk diffusion 
method. 
Results: Among the 594 patients examined, 158 were HIV+ D+, 
121 were HIV- D+, 160 were HIV+ D-, and 155 were HIV- D-. 
The main etiologies of diarrhea were different according to HIV 
serostatus of patients. In immunocompetent adults the main 
causes of diarrhea were Shigella sp (12.4%), Entamoeba his- 
tolytica (10.7%) Salmonella enterica (6.6%), and Giardia (4.9%). 
In the immunocompromised host the more frequent pathogens 
were enteroaggregative E. co/i (19.6%), Microsporidium (9.4%), 
Cryptosporidjum sp (8.2%), Rotavirus (8.2%) Shigella sp (7.6%) 
Candida a/b/cans (7.6%), E. histolytica (5.1%), S. enterica (4.4%), 
and lsospora belli (4.4%). Also, Blastocystis hominis has to be 
considered as an opportunistic parasite, because it was iden- 
tified only in HIV-infected patients, with higher prevalence in 
adults with diarrhea (2.5% in HIV+ D+ patients; 0.6% in HIV+ 
D- patients). High level of asymptomatic carriage of Ascaris 
lumbricoides and Trichuris trichiura and some cases of multiple 
infections were observed. Fungi, Cryptosporidium sp and 
Microsporidium sp, were often identified in patients with low 
CD4 counts (range, 79-250 cells/ml). Independently from HIV- 
serostatus, CD4 count was lower in diarrheic persons, sug- 
gesting that diarrhea is a debilitating illness and that effective 
management of diarrhea can prevent immunosuppression. Iso- 
lated enteropathogenic strains displayed high resistance to most 
antibiotics used in Senegal for treating diarrhea (ampicillin, tetra- 
cycline, cotrimoxazole); they were susceptible to amikacin, gen- 
tamicin, and norfloxacin. 
Conclusion: These epidemiologic data suggest that guidelines 
for the management of diarrhea during HIV infection in Dakar 
should be updated. 
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According to new estimates from the joint United Nations 
Programme on human immunodeficiency virus (HIV) and 
the acquired immunodeficiency syndrome (AIDS) 
(UNAIDS) and the World Health Organization (WHO), 
about 33 million adults are living with HIV, and close to 
70% of the total of HIV-positive people are from sub&ha- 
ran Africa. Diarrheal illnesses remain a major clinical prob- 
lem for patients infected with HN; particularly those with 
the life-threatening AIDS. In Africa, diarrhea occurs in 60 
to 90% of HIV infection’ and “slim disease,” prolonged 
diarrhea, and wasting usually, attributable to coccidian 
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parasites, is pathognomic of AIDS in central Africa.‘,* Set-o 
prevalence of HIV in Senegal is about 1.6%, and nearly 
80% of adults with AIDS present initially with diarrhea 
and weight loss. A wide variety of bacterial, viral, and par- 
asitic pathogens can cause diarrhea in patients with 
advanced HIV infection. Although diarrhea occurs fre- 
quently, its optimal management remains controversial3 
Bacterial pathogens in AIDS patients may manifest dif- 
ferently from infections in immunocompetent hosts. 
Other pathogens, including Cryptosporidium and 
Microsporidium, are difficult to diagnose and have no 
effective therapy. Moreover, enteric viruses and HIV itself 
may contribute to the diarrhea.* Only limited informa- 
tion is available regarding the etiology, clinical conse- 
quences, and immunologic effects of infection with 
diarrheal agents in the immunocompromised host. Con- 
sequently, the authors conducted a survey in Senegal 
among HIV-seropositive and HIV-seronegative subjects to 
identify major types and prevalences of bacteria, para- 
sites, fungi, and Rotaviruses associated with diarrhea in 
adult patients, with the goal to provide guidance to physi- 
cians for case management. 
MATERIALS AND METHODS 
Study Population 
Four groups of patients hospitalized in two Senegalese 
hospitals (Hopita Principal and Fann Teaching Hospital) 
were examined: group 1 comprised HIV-infected patients 
with diarrhea (HIV+ D+); group 2, HIV seronegative 
patients with diarrhea (HIV- D+); group 3, HIV-infected 
patients without diarrhea (HIV+ D->; group 4, HIV 
seronegative controls without diarrhea (HIV- D-). Con- 
trol stool specimens (group 3 and group 4) were obtained 
from HIV-seropositive and HIV-seronegative adults 
selected from individuals who had no history of diarrheal 
illness during the preceding month. Cases (group 1 and 
group 2) were HIV-seropositive and HIV-seronegative hos- 
pitalized adults with diarrhea who had not received 
antibiotics during the previous 2 weeks, All subjects 
underwent complete physical examination and patient 
environment and history were recorded on a standardized 
questionnaire filled out by a physician. All aspects of the 
study were approved by the ad hoc Ethical Committee, 
and prior informed consent was obtained from included 
subjects. 
HIV Serology and CD4 Counts 
Human immunodeficiency virus serology was tested by 
two enzyme immunoassays (Genelavia Mixt, Sanofi Diag- 
nostics Pasteur, Marries-la-Coquette, France, and Vironostika 
HIV Uni-Form II, Organon Teknika, Boxtel, The Nether- 
lands), and confirmed by Western blotting (New Iav Blot, 
Sanofi Diagnostics Pasteur). CD4 lymphocyte counts were 
undertaken using a laser-based FACSCount system (Becton 
Dickinson Irnmunocytometry Systems, San Jose, CA, USA) 
for directly determining absolute CD4 count. 
Microbiologic Analysis 
All cases and controls had stool specimens collected and 
processed in the same way No transport media were used; 
specimens were quickly examined in the laboratory after 
collection. Freshly collected stool samples were examined 
immediately after collection, by dark-field microscopy, for 
motile bacteria, trophozoites, red blood cells, and leuko- 
cytes. Stool specimens were treated with saline and iodine 
preparations and examined for intestinal parasites; fur- 
thermore, formalin-ether concentrates and smears stained 
with Merthiolate-iodine-formaldehyde solution were pre- 
pared from each of the specimens and examined micro- 
scopically. Coccidia and Microsporidia were detected 
respectively by Kinyoun stain and modified trichrome 
stain with a high concentration of chromotrope 2 R.5 The 
modified Kinyoun acid-fast stain was used for detection of 
mycobacteria. Rotaviruses were identified with a com- 
mercial latex agglutination test (Sanofi Diagnostics Pas- 
teur). Bacteria such as Escberichia coli, Salmonella spp, 
Shigella spp, Yersinia spp,Aeromonas spp, Plesiomonas 
spp, Vibrio spp, Campylobacter spp, and fungi were iden- 
tified by standard methods.6 Identification of CZostridium 
spp was undertaken only if gram-positive rods were seen 
after Gram staining. Genotypic differentiation of patho- 
genic E. coli strains was performed by polymerase chain 
reaction (PCR), according to Tornieporth et al.’ Oligonu- 
cleotide primers to detect enterotoxigenic E. coli 
(ETEC),‘-“’ enteroinvasive E. coli (EIEC), enterohemor- 
rhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), 
enteroaggregative E. coli (ILAggEC), and diffuse adherent 
E. coli (DAEC) by PCR tests are shown in Table 1. Pheno- 
typic characterization of pathogenic E. coli was performed 
by a microtiter ganglioside enzyme linked immunosor- 
bent assay (GMl-ELISA) for the thermolabile enterotoxin,” 
the suckling mouse assay for the thermostable entero- 
toxin,‘* and the guinea pig keratoconjunctivitis assay for 
enteroinvasive E. coli.” All E. coli isolates were examined 
for HEp-2 cell adherence in eight-well chamber slides 
(LAB-TEK, Nunc Inc., Naperville, IL, USA), according to 
Vial et al.‘* HEp-2 cell adherence was characterized as 
localized (IA), aggregate (AA), or diffuse (DA) adherence. 
HEp2 adherence pattern and virulence gene were per- 
formed on five colonies of E. coli. Escherichia coli was 
considered to be the etiologic agent of the diarrheal ill- 
ness when a significant virulence gene was identified on 
at least three of five tested colonies. Serotypes of Salmo- 
nella spp and ShigeZZa spp were determined using slide 
agglutination.The antimicrobial susceptibility of bacterial 
enteropathogens was determined using the disk diffusion 
test.15 
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Table 1. Oligonucleotide Primers Used to Differentiate Pathogenic Enteric Escherichia co/i 
Target Gene (Enteropathogen) Primer Sequences 
Amp/icon Size 
Location (base pairs) From 5’ end (base pairs) 
I  
bfp gene (EPEC) 5’CAATGGTGClTGCGC~GCT3’ 119-138 325 
S’GCCGCTUATCCAACCTGGT3’ 443-422 
eaeA (EPEC) 5’GCAA4lTTAGGTGCGGGTCAGCGlT3’ 2412-2436 494 
5’GGCTCAAlTTGCTGAGACCACGGlT3’ 2905-2881 
LT (ETEC) gene 5’GCGACMAlTATACCGTGCT3’ 59-76 707 
5’CCGAATTCTGTFATATATGT3’ 765-746 
Sta (ETEC) gene 5’CTGTAnGTCTllTXACCT3’ 79-98 182 
5’GCACCCGGTACAAGCAGGAT3’ 26ct241 
ipaH (EIEC) 5’GCTGGAAAAACTCAGTGCCT3’ 1061-l 080 424 
5’CCAGTCCGTAAA‘TTCATTCT3’ 1484-l 465 
E&W 5’CTGGCGPAAGACTGTATCAT3’ l-64 630 
5’CAATGTATAGAAATCCGCTGlT3’ 765-693 
SLT 1 5’GAAGAGTCCGTGGGATTACG3’ 1191-1210 130 
5’AGCGATGCAGCTATMATAA3’ 1301-l 320 
SLT2 5’TWACCACACCCACGGCAGT3’ 426-445 346 
5’GCTCTGCATGCATCTCTGGT3’ 752-771 
afa (DAEC) 5’GCTGGGCAGCAAACTGATAACTCTC3’ 889-9 14 750 
5’CATCAAGCTG~GTTCGTCCGCCG3’ 122-l 46 
bfp = bundle-forming pilus; EPEC = enteropathogenic E. co/i; eaeA = E. co/i attaching and effacing gene A; LT = heat-labile anterotoxin; ETEC = anterotoxiganic E. 
co/i; STa = heat-stable enterotoxin; ipaH = invasion plasmid H; EIEC = enteroinvasive E. co/i; EAggEC = enteroaggregative E. co/i; SLT 1 = Shiga-Iike toxin 1; 
SLT 2 = Shiga-like toxin 2; DAEC = diffuse adherent E. co/i. 
Statistic Analysis 
Stastical analyses were performed using Epi Info, version 
6.01 (Centers for Disease Control and Prevention, Atlanta, 
GA, USA) and SAS, version 6.12 (SAS Inc., Gary, NC, USA). 
For continuous variables normally distributed, means 
were compared using Student’s t-test or the analysis of 
variance. Categoric variables were compared using the 
cm-squared test and Fisher’s exact test where appropriate. 
Potential risk factors of diarrhea among HIV-infected 
individuals were analyzed by univariate methods to deter- 
mine possible inclusion in the multivariate model. All vari- 
ables associated with diarrhea with a P-value of less than 
0.3 were included in the multivariate analysis. Logistic 
regression analysis was performed to calculate odds ratio 
(OR) and 95% confidence interval (95% CD. 
RESULTS 
Among the 594 stool and blood samples analyzed, 279 
were from cases and 315 were from controls.The char- 
acteristics of the studied population are described in 
Table 2. The more frequent serotype, HIV-l, was identi- 
fied in 90.9% (289/318) of the population; HIV-2 was 
identified in 5.3% (17/318), and 3.8% (12/318) of the 
study population were co-infected by both serotypes 
HIV-l and HIV-2. As expected, CD4 geometric mean cell 
counts were lower in HIV-infected than in HIV- 
seronegative patients in cases as well as in controls 
(P < 0.000001). CD4 count was also significantly lower 
in diarrheic patients in HIV+ (P = 0.0007) as well as in 
HIV- (P < 0.0001) patients. There were no significant 
differences of age or gender among the four groups. 
Identified bacterial pathogens are listed in Table 3. 
No Yersinia spp, Vibrio spp, Plesiomonas spp, EHEC, 
Clostridium perfringens, or Mycobacterium spp were 
identified during this study Shigella spp and Salmonella 
spp were the most frequently identified bacterial 
pathogens during acute diarrhea; 28 Shigella were iden- 
tified: Sbigella jlexneri (n = 14), Shigella dysenteriae 
(n = 12) and Shigella sonnei (n = 2); no Shigella boy- 
dii were identified. All Shigella strains were from cases 
except one S. sonnei isolated from a HIV-seronegative 
patient without diarrhea. No asymptomatic carriage of 
Shigella was observed in HIV-infected patients. Eighteen 
strains of Salmonella enterica (15 in cases; 3 in con- 
trols) were identified. The various serotypes were 
S. enteritidis (5 among cases; 1 among controls), S. ken- 
tacky (2 among cases), S. typhi (1 among cases), 
S. sangera (1 among cases), S. magherafelt (1 among 
cases), S. tambacounda (2 among cases; 1 among con- 
trols), S. glostrup (1 among cases), and S. typhimurium 
Table 2. Characteristics of Studied Population 
Parameter D+ HIV+ (n = 158) D+ HIV- (n = 121) LF HIV+ (n = 160) E- HIV- (n = 155) 
Age (mean k SD) 37.8 (29.2) 38.6 (214.6) 39.3 (28.4) 38.1 (214.0) 
Gender (% male) 57.5 64.4 65.2 58.7 
CD4 count/mm3 (mean -C SD) 109.9 (2205.3) 674.9 (kl97.9) 187.6 (k197.9) 839.0 (571.9) 
D = diarrhea; HIV = human immunodeficiency virus: + = positive: - = negative. 
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Table 3. Prevalence of Bacterial Pathogens 
D+ H/V+ D+ HIV- D- HIV+ D- HIV- 
n= 758(%) n = 721 (%) n=160@) n= 155(%) 
Enteroaggregative E. co/i* 31 (19.6) 8 (6.6) 5 (3.1) 4 (2.6) 
Enteroinvasive E. co/i + 5 (3.2) 4 (3.2) 0 0 
Shigella 12 (7.6) 15 (12.4) 0 1 (0.6) 
Salmonella 7 (4.4) 8 (6.6) 1 (0.6) 2 (1.3) 
Campylobacter 1 (0.6) 2 (1.6) 0 0 
Aeromonas 1 (0.6) 2 (1.6) 0 0 
Klebsiella 7 (4.4) 0 0 0 
Citrobacter 3 (1.9) 1 (0.8) 0 0 
*E. co/i displaying enteroaggregative pattern on HEp-2 cells and/or with the EAgg PCR gene; F. co/i positive in the guinea pig keratoconjunctivitis assay or with ipaH 
gene. D = diarrhea; HIV = human immunodeficiency virus; + = positive: - = negative. 
(2 among cases and 1 among controls). Two Cumpy- 
Zobacter jejuni infections were identified in HIV-D+ 
patients, and one Campylobacter fetus was identified in 
a seropositive patient with persistent diarrhea. Three 
strains of Aeromonas spp were identified in cases: two 
strains of A. hydropila in HIV-seronegative patients and 
one A. sob& (now referred to as A. veronii bv sob&) 
in an HIV seropositive patient. HEp-2 cell adherence pat- 
terns of E. coli strains showed three morphologic pat- 
terns: diffusely adherent E. coli was the most frequent 
pattern and was not differently isolated from cases and 
controls. The enteroaggregative HEp-2 adherence pat- 
tern was more often displayed by E. coli strains isolated 
from HIV-positive patients with diarrhea (Table 4). Con- 
cerning the prevalence of different E. coli pathotypes 
identified by PCR (see Table 4), at least one target gene 
was found in 205 (34.5%) patients, and a target gene was 
found more often in cases (125/279,44.8%) than in con- 
trols @O/315,25.3%), P = 0.00001. Results show a high 
prevalence of afa gene in cases (66/219) as well as in 
controls (63/3 15); consequently pathogenic E. coli were 
E. coli strains with at least one virulence factor different 
from afu gene. Inversely, enteroaggregative and entero- 
invasive E. coli seem to be closely related respectively to 
chronic and acute diarrhea. Isolation of enteroinvasive E. 
coli (ipaH gene ) was not dependent on HIV-serostatus, 
and no asymptomatic carriage was found for this patho- 
type. In contrast, enteroaggregative E. coli (EAgg gene) 
was isolated more frequently in HIV-seropositive patients 
(either alone or in association with other virulence 
genes: 34/318 in HIV-positive patients vs. 7/276 in HIV- 
negative patients). More than one virulence gene was 
more often observed in HIV-seropositive diarrheic 
patients (HrV+ D+ vs. HIV- D+: 21/158 vs. 3/121, P = 
0.01; HIV+ D+ vs. HIV+ D-: 21/158 vs. 6/160, P = 0.2). 
Only one strain of E. coli carrying three virulence genes 
(afu, eae, EAgg) was identified in an HIV-seropositive 
patient with chronic diarrhea. Except for the ipaH gene, 
other virulence genes were identified in patients with 
CD4 count ranging from 11 to 259 cells/mm3. There was 
good correlation between genotypic and phenotypic 
characterization of enterotoxigenic and enteroinvasive 
Table 4. HEp-2 Cell Adherence Pattern and Virulence Genes of Isolated f. co/i 
D+ H/V+ n = 158 (%) D+ HIV-n = 121 (%) D- HIV+ n = 760 (%) D- HIV- n = 155 (%) 
HEp-2 cell adherence pattern 
Adherent 96 (60.7) 45 (37.1) 
Diffused adherence 
54 (33.7) 43 
49 (31 .O) 
(27.3) 
31 (19.6) 40 (25.3) 33 Localized 16 10.1) (21.3) 
6 11 5 Aggregate (3.8) (6.8) 31 (19.6) (3.2) 8
(5.1) 
3 
(1.9) Prevalence of virulence (3.2) 
genes 
bfp gene 4 (2.5) 1 (0.8) 3 (1.9) 
eae gene 4 (2.5) 1 LTIST (0.8) 2 (1.2) 7 
gene 
2 (1.3) (0.6) 
- 
ipaH gene 5 (3.2) 4 
WgEC 
(3.2) 
20 (12.6) 2 2 SLT 1 (1.6) (1.2) 3 (1.9) - 
- 
SLT2 
afa gene 3; (22.1) 31 (25.1) 33 Association of virulence (20.6) 30 (19.3) 
genes 
afa + bfp gene 
afa + EAggEC 1; (6.9) 
3 (1.9) - 
1 1 afa + ipaH (0.6) 1 5 (3.1) (0.8) 
eae + bfp gene 
2 (1.6) 2 
4 (2.5) 
(1.2) 
1 (0.6) 
(0.6) 
afa + eae + bfp 2 (1.2) - 
gene 
1 (0.6) 
D = diarrhea; HIV = human immunodeficiency virus; + = positive; - = negative; bfp = bundle-forming pilus; LT = heat-labile; ST = heat-stable; 
EAggEC = enteroaggregative E. co/i; SLT = Shiga-like toxin. 
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Table 5. Antibiotic Susceptibility Pattern of Isolated Bacterial Enteropathogens 
/so/ate and Number 
Percentage Resistant to Antibiotics 
Characteristics Tested AM T/C CF FOX C7X AMC CAZ /PM GM TM AN UB cs NOR SXT TE 
Salmonella spp 18 19 13 13 0 0 0 Cl 0 0 0 0 0 0 0 6 69 
Shigella spp 28 100 
Campylobacter spp 3 67 
89 6: 00 40 0 077 44 0 100 100 
0 0 
6: 0 
33 0 0 0 0 0 0 0 0 100 0 
Aeromonas spp 3 100 67100 0 0 0 0 0 0 33 33 100 
Klebsiella spp 7 100 100 29 29 0 14 0 0 i 0 0 430 0 57 71 
Citrobacter spp 4 50 25 75 0 0 0 0 0 250 25 25 0 25 50 50 
Pathogenic enteric E. co/i 9 67 67 22 0 0 22 0 0 0 0 : 0 0 0 67 89 
(EIEC) 
Pathogenic enteric E. co/i 48 85 56 67 4 0 29 0 0 0 0 0 0 0 0 79 96 
@%mW 
AM = ampicillin; TIC = ticarcillin; CF = cefalotin; FOX = cefoxitin; ClX = cefotaxime; AMC = amoxicillin clavulanate; CA2 = cef&idime; IPM = imipenem; GM = 
gentamicin; TM = tobramycin; AN = amikacin; UB = flumequin; CS = colistin: NOR = norfloxacin; SXT = trimethoprim-sulfamethoxazole; EIEC = enteroinvasive E co/i; 
EAggEC = enteroaggregative E. co/i. 
E. coli. Two strains were positive in the GMl-ELBA test 
for heat-labile enterotoxin and in the suckling mouse 
model assay for heat-stable enterotoxin; all strains car- 
rying @aH gene were positive for the guinea pig kera- 
toconjunctivitis Sereny test. Unusual bacterial etiologies 
like Klebsiella pneumoniae (n = 7), Citrobacter freundii 
(n = 4) were found in immunocompromised patients 
with diarrhea. One of the Citrobacter spp strains was 
isolated from a 6&-year-old HIVseronegative woman with 
diabetes. The other strains were from HIV-seropositive 
patients with very low CD4 counts. In all these cases 
oral antibiotic therapy proved to be effective. These 
opportunistic bacterial pathogens were examined for 
HEp-2 cell adherence, and all showed a diffuse adher- 
ence pattern except three strains of K. pneumoniae, 
which displayed the “stacked-brick” aggregative adher- 
ence pattern typical of enteroaggregative E. coli strains 
and one strain of C. freundii (different from the one iso- 
lated from the 68-y-old woman) displaying the localized 
adherence attaching and effacing pattern typical of 
enteropathogenic E. coli. Polymerase chain reaction for 
E. coli virulence genes was negative for almost all strains 
except one K.pneumoniae with EAgg gene and one C. 
freundii gene with eae gene. Table 5 illustrates the 
antibiotic susceptibility of the 117 strains of bacterial 
enteropathogens recovered from cases and controls. All 
isolates were susceptible to am&a&, gentamicin, broad- 
spectrum cephalosporin, and ciprofloxacin. Shigella spp 
and pathogenic E. coli were highly resistant to ampicillin, 
ticarcillin, cotrimoxazole, and tetracycline. Most enteropath- 
ogenic strains remained susceptible to ampicillin and clavu- 
lanic acid, third generation cephalosporins and 
fluoroquinolones. Interestingly, Salmonella strains remain 
susceptible to almost all antibiotics except tetracyclines. 
Prevalence of different parasites, C. albicans, and 
Rotaviruses are shown in Table 6. A high level of asymp- 
tomatic carriage of A. lumbricoides and Trichuris 
trichiura was observed. In the immunocompetent 
patients, the two main parasitic agents involved in diar- 
rhea were Entamoeba histolytica and Giardia lamblia. 
The main opportunistic parasites are Microsporidium 
(9.4%), Cryptosporidium (8.2%), and Isospora belli 
Table 6. Prevalence of Parasites, Candida albicans, and Rotavirus 
D+ HIV+ n = 128 D+ H/V-n = 727 D- H/V+ n = 160 D- H/V- n = 155 
Ascaris lumbricoides 13 (8.2) 13 (10.7) 10 (6.2) 13 (8.2) 
Trichuris trichiura 18 (11.4) 12 (9.9) 11 (6.2) 16 (10.3) 
Strongyloides stercoralis 3 (1.9) 1 (0.8) 0 0 
Taenia saginata 
Entamoeba histolytica : 
2 (1.6) 0 0 
(5.1) 13 (10.7) 1 (0.6) 3 (1.9) 
Giardia lamblia 3 (1.9) 6 (4.9) 0 2 (1,3) 
Trichomonas intestinalis 1 (0.6) 0 0 
Cryptosporidium 13 (8.2) : (1.6) 2 (1.2) 1 (0.6) 
Microsporidium 15 (9.4) 1 (0.8) 2 (1.2) 0 
lsospora be//i 7 (4.4) 0 2 (1.2) 0 
lsospora hominis 2 (1.3) 1 (0.8) 0 0 
Blastocystis hominis 4 (2.5) 0 1 (0.6) 0 
Candida albicans 12 (7.6) 1 (0.8) 1 (0.6) 0 
Rotavirus 13 (8.2) 3 (2.5) 2 (1.1) 0 
D = diarrhea: HIV = human immunodeficiency virus; + = positive: - = negative. 
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Table 7. Potential Risk Factors of Diarrhea 
among HIV-Infected Adults in Senegal 
Factor OR 95% Confidence Interval P-Value 
Age 
2 40 y Reference 
< 40 y 1.39 0.76-2.55 0.28 
CD4 cells 
2 500 Reference 
200 5 CD4 < 500 2.60 0.58-l 1.76 0.21 
CD4 < 200 4.74 1.18-19.01 0.03 
Living conditions 
Good (tiled floor) Reference 
Poor (mud floor) 2.26 1.04-4.90 0. 04 
(4.4%). Blustocystis hominis was isolated only in sero- 
positive patients, with a higher prevalence in patients 
with diarrhea. Fungi were considered to be potential 
enteric pathogens when no other known enteropatho- 
genie agent was identified and when they represented 
up to 50% of microorganisms observed per field under 
microscope. Twelve cases of massive infestation by Cun- 
dida ulbicans were observed in HIV-infected patients 
wth diarrhea. In almost all these cases patients were also 
undergoing oral candidiasis. Candida albicans was once 
isolated as the sole pathogen in an HIV-negative patient; 
in all cases fungi were isolated in patients with very low 
CD4 counts (range, 42-78 cells per mm’). Rotaviruses 
were identified in 13 HIV-infected patients and in two 
immunocompetent patients. Co-infection by two or more 
enteropathogenic agents was observed 11 times: Salmo- 
nella spp + Microsporidium (n = l), Cryptosporidium 
+ A. lumbricoides (n = l), Salmonella + G. lamblia + T. 
trichiura (n = l), Microsporidium + E. coli + A. lumbri- 
coides (n = 2), I. belli + 1: trichuria + A. lumbricoides (n 
= l), Cryptosporidium + C. albicans (n = 2), Shigella + 
A. lumbricoides (n = 2). 
The risk of developing diarrhea increased progres- 
sively as CD4 counts fell below 200 cells/mm” (Table 7). 
The other independent risk factor was poor housing. Also 
patients younger than 40 years of age tended to be at 
higher risk. 
DISCUSSION 
Diarrhea is a prominent feature of AIDS in adults, and it 
causes significant morbidity in HIV-infected persons. This 
study confirms the association between persistent diar- 
rhea and enteroaggregative E. coli previously suspected 
in other countries.‘” However, some of the isolates from 
group 1 patients displayed the “stacked brick” aggregative 
adherence pattern on HEp-2 cells but lacked the typical 
virulence factor of enteroaggregative E. coli strains 
(EAggEC gene). This phenomenon has been observed by 
other investigators, l7 and it suggests existence of other 
virulence factors. The current results suggest that afa 
gene is not a significant virulence gene in adults in 
Senegal, but it is often associated with other E. COD viru- 
lence genes. Further investigations would be useful to 
determine whether afa gene is acting as a cofactor for 
other virulence genes. 
Eight different serotypes were identified from the 18 
isolated strains of S. enterica; a similar study conducted 
in Bangui (Central African Republic) showed only two 
different serotypes from 39 strains.‘” The limited diversity 
of serotypes in Bangui can be explained by the geo- 
graphic situation of the country and the quasi absence of 
imported foods and crops. In contrast, spirochetes were 
found in Bangui and not in Dakar, where 80% of the pop- 
ulation is muslim and has no contact with pigs. Identifi- 
cation of A. sobria (A. veronii bv sobria) as an etiologic 
agent of diarrhea in an HIV-infected patient emphasizes 
the implication of this bacteria in diarrhea of the immuno- 
compromised host. A case of acute diarrhea produced 
by A. sobria (A. veronii bv sobria) in a patient colec- 
tomized for Crohn’s disease was reported by de Sola Earle 
et a1.19 Overall, the literature suggests that Aeromonas 
sp, once mainly considered an opportunistic pathogen 
in immunocompromised humans, is now implicated as an 
etiologic agent in numerous clinical situations involving 
immunocompetent individuals of all age groups. The 
alarming rates of resistance to the most affordable antibi- 
otics found in Dakar (tetracycline, cotrimoxazole) pro- 
vide evidence of the need for more rational use of 
antibiotics. In fact high resistance to tetracycline emerged 
in Senegal after an intensive use of this drug during the 
cholera epidemic in 1995.2” 
In the present study, about 30% of cases of diar- 
rhea were of unknown etiology An extensive evaluation 
including stool studies and endoscopic biopsies of both 
colon and small intestine has been widely recom- 
mended to identify all potential pathogenic organisms.” 
Stool viruses, such as adenovirus and coronavirus, were 
described as the possible causes of diarrhea in HIV- 
infected patients in Berlin. *l Unusual pathogens such as 
spirochetes have been described as a possible cause of 
diarrhea in HIV-infected persons in Central African 
Republic. l9 Moreover, enteric viruses and HIV itself may 
contribute to the diarrhea. In addition to microbes, 
other factors, such as medication, immune dysregula- 
tion, automatic dysfunction, and nutritional supple- 
mentation, play a substantial role in diarrhea in patients 
with AIDS.* 
The present findings suggest that coccidia should be 
considered to be etiologic agents for immunocompro- 
mised adults; the same results have been observed in 
other developing African countries.22 Conflicting evi- 
dence exists as to whether B. hominis should also be 
included among the infectious agents capable of causing 
HIV-related diarrhea. Albrecht et al found that association 
of B. hominis with clinical symptoms was not evident, 
and it is frequently associated with the concurrent iso- 
lation of other enteric pathogens.23 In the present study, 
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B. hominis has to be considered as an opportunistic par- 
asite, because it was identified only in HIV-infected 
patients, with higher prevalence in adults with diarrhea, 
and in these cases it was not associated with other 
pathogens. 
As found by other investigators,24 results of this study 
suggest that declining CD4 T-lymphocyte counts are asso- 
ciated with increased risk of diarrhea. Furthermore, the 
ftnding of lower CD4 counts among patients with diar- 
rhea regardless to their HIV serostatus shows that diar- 
rhea is a debilitating illness and suggests that effective 
management of diarrhea can prevent lmnmnosuppression. 
CONCLUSIONS 
The principles of HIV and AIDS therapy include reduc- 
tion of HIV replication by antiretrovlral agents, prophy- 
laxis against the common opportunistic infections, and 
treatment, followed by subsequent lifelong maintenance 
therapy for infections when they do occur.25 Many devel- 
oping countries cannot afford antiretroviml therapy; there- 
fore, effective management of opportunistic infections, 
including diarrheal diseases, remains a realistic alterna- 
tive to improve the quality of life of patients living with 
HIV and to delay the evolution to AIDS. Guidelines for 
managing bacterial diarrhea in developing countries 
should be updated, because in this study cotrimoxazole, 
one of the recommended antimicrobial agents for the 
treatment of diarrhea, has been shown to have little activ- 
ity against Shigella spp, Salmonella spp, and entero- 
aggregative E. coli. 
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